NXTG fundamentals
Key facts
Market capitalization39.82 MILS
Basic EPS (TTM)−0.11ILS
Founded1982
CEOAbraham Dreazen
Websitenxtg.co.il
About
NEXTAGE Therapeutics Ltd. operates as a global pharmaceutical company. It engages in the development of cannabinoid-based products. The company was founded on May 18, 1982 and is headquartered in Ness Ziona, Israel.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−1,400.0%
−1,100.0%
−800.0%
−500.0%
−200.0%
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
−3.00 M
−2.00 M
−1.00 M
0.00
1.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Dividends
Dividend yield, history and sustainability
NXTG does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company